Last updated on September 2018

Effects of Denosumab on Bone Mineral Density in Women With Anorexia Nervosa: A Pilot Study

Brief description of study

This protocol is a randomized, double-blind, placebo-controlled clinical trial which aims to investigate the effect of denosumab on BMD in women with anorexia nervosa. The investigators hypothesize that 12 months of denosumab administration will result in an increase in bone mineral density, decrease in markers of bone resorption and improvement in bone microarchitecture in osteopenic women with anorexia nervosa compared with placebo.

Clinical Study Identifier: NCT03292146

Contact Investigators or Research Sites near you

Start Over

Karen Miller, MD

Massachusetts General Hospital
Boston, MA United States
  Connect »